OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma
James T. Topham, Erica S. Tsang, Joanna M. Karasinska, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
James T. Topham, Erica S. Tsang, Joanna M. Karasinska, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 529
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 529
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
Anna M. Varghese, Maria Perry, Joanne F. Chou, et al.
Nature Medicine (2025)
Open Access | Times Cited: 3
Anna M. Varghese, Maria Perry, Joanne F. Chou, et al.
Nature Medicine (2025)
Open Access | Times Cited: 3
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer
Harshabad Singh, Rachel B. Keller, Kevin S. Kapner, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 22, pp. 4627-4643
Open Access | Times Cited: 27
Harshabad Singh, Rachel B. Keller, Kevin S. Kapner, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 22, pp. 4627-4643
Open Access | Times Cited: 27
Exploiting pancreatic cancer metabolism: challenges and opportunities
Maria Chiara De Santis, Bruno Bockorny, Emilio Hirsch, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 6, pp. 592-604
Open Access | Times Cited: 14
Maria Chiara De Santis, Bruno Bockorny, Emilio Hirsch, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 6, pp. 592-604
Open Access | Times Cited: 14
Fusion genes in pancreatic tumors
Αναστάσιος Γκουντάκος, Aatur D. Singhi, C. Benedikt Westphalen, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 430-443
Open Access | Times Cited: 9
Αναστάσιος Γκουντάκος, Aatur D. Singhi, C. Benedikt Westphalen, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 430-443
Open Access | Times Cited: 9
Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling
Janina Werner, Patrick Bernhard, Miguel Cosenza‐Contreras, et al.
Neoplasia (2023) Vol. 36, pp. 100871-100871
Open Access | Times Cited: 18
Janina Werner, Patrick Bernhard, Miguel Cosenza‐Contreras, et al.
Neoplasia (2023) Vol. 36, pp. 100871-100871
Open Access | Times Cited: 18
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Julianne M. Szczepanski, Mark A. Rudolf, Jiaqi Shi
Cancers (2024) Vol. 16, Iss. 4, pp. 794-794
Open Access | Times Cited: 7
Julianne M. Szczepanski, Mark A. Rudolf, Jiaqi Shi
Cancers (2024) Vol. 16, Iss. 4, pp. 794-794
Open Access | Times Cited: 7
KRAS mutation status integrated with RNA subtyping improves prognostic modeling in FOLFIRINOX-treated metastatic pancreatic cancer
Marjolein F. Lansbergen, Mark P.G. Dings, Jan Köster, et al.
Med (2025), pp. 100601-100601
Open Access
Marjolein F. Lansbergen, Mark P.G. Dings, Jan Köster, et al.
Med (2025), pp. 100601-100601
Open Access
Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm
Phoebe T. M. Cheng, James T. Topham, Ayman Aldeheshi, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Phoebe T. M. Cheng, James T. Topham, Ayman Aldeheshi, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Metabolic reprogramming in cancer and senescence
Yuzhu Zhang, J. Tang, Can Jiang, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Yuzhu Zhang, J. Tang, Can Jiang, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
Brian Mooney, Gian Luca Negri, Taras Shyp, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 5, pp. 1022-1037
Open Access | Times Cited: 12
Brian Mooney, Gian Luca Negri, Taras Shyp, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 5, pp. 1022-1037
Open Access | Times Cited: 12
Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
Tuan Hoang, Erica S. Tsang
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Tuan Hoang, Erica S. Tsang
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Unlocking the Genetic Secrets of Pancreatic Cancer: KRAS Allelic Imbalances in Tumor Evolution
Vasiliki Liaki, Blanca Rosas-Pérez, Carmen Guerra
Cancers (2025) Vol. 17, Iss. 7, pp. 1226-1226
Open Access
Vasiliki Liaki, Blanca Rosas-Pérez, Carmen Guerra
Cancers (2025) Vol. 17, Iss. 7, pp. 1226-1226
Open Access
Oncogenic gene fusions in cancer: from biology to therapy
Stephen V. Liu, Misako Nagasaka, Judith Atz, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Stephen V. Liu, Misako Nagasaka, Judith Atz, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma
Brandon M. Huffman, Haley Ellis, Alexander C. Jordan, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6223-6223
Open Access | Times Cited: 16
Brandon M. Huffman, Haley Ellis, Alexander C. Jordan, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6223-6223
Open Access | Times Cited: 16
Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer
Jincheng Han, Jiaqian Xu, Yonghong Liu, et al.
Genes & Development (2023) Vol. 37, Iss. 17-18, pp. 818-828
Open Access | Times Cited: 10
Jincheng Han, Jiaqian Xu, Yonghong Liu, et al.
Genes & Development (2023) Vol. 37, Iss. 17-18, pp. 818-828
Open Access | Times Cited: 10
Multi-level integrative analysis of the roles of lncRNAs and differential mRNAs in the progression of chronic pancreatitis to pancreatic ductal adenocarcinoma
Zhirong Zhao, Qiang Luo, Yi Liu, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Zhirong Zhao, Qiang Luo, Yi Liu, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series
Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project
Alexander Semaan, Vincent Bernard, Justin Wong, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 10, pp. 2062-2073
Open Access | Times Cited: 5
Alexander Semaan, Vincent Bernard, Justin Wong, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 10, pp. 2062-2073
Open Access | Times Cited: 5
Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer
Ahmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Targeted Oncology (2024) Vol. 19, Iss. 5, pp. 679-689
Closed Access | Times Cited: 1
Ahmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Targeted Oncology (2024) Vol. 19, Iss. 5, pp. 679-689
Closed Access | Times Cited: 1
Jana Krüger, Anja Fischer, Markus Breunig, et al.
The Journal of Pathology (2023) Vol. 261, Iss. 2, pp. 139-155
Open Access | Times Cited: 3
Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic Cancer
Rachael A. Safyan, Eejung Kim, Emmelie Dekker, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access
Rachael A. Safyan, Eejung Kim, Emmelie Dekker, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access
Role of molecular biology in the management of pancreatic cancer
Alice Boilève, Cristina Smolenschi, Aurélien Lambert, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 7, pp. 2902-2914
Open Access
Alice Boilève, Cristina Smolenschi, Aurélien Lambert, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 7, pp. 2902-2914
Open Access
Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles
Hassan A. Ali, Joanna M. Karasinska, James T. Topham, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access
Hassan A. Ali, Joanna M. Karasinska, James T. Topham, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access
Neutrophil Extracellular Trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting metastasis of pancreatic tumours
Paul C. McDonald, James T. Topham, Shannon Awrey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Paul C. McDonald, James T. Topham, Shannon Awrey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
